Investor Stock List
Ranked #3,348 of 8,699 institutional investors

Spruce Street Capital LP

New York, NY

$570M
US stock portfolio at live prices · today −$16.9M (−2.88%)
Live prices, last trade 12:11 PM ET
Value at quarter end (Q3 2026)
$629M
Change from Q2 2026
+$119.3M (+23.41%)
Positions
29 · 5 new, 0 sold out
Filed
Nov 13, 2026

Not counted in the ranking: none$174M of holdings we could not match to a US listing are included at their reported quarter-end value.

Holdings

Q3 2026 13F, live prices
LBRX 9.54%RLAY 8.36%ANRO 7.39%DNTH 5.25%SVRA 4.05%
StockSharesValue, live% of portfoliovs Q2 2026
LBRX LB Pharmaceuticals Inc1,404,779$54.4M9.54%Added +2%
RLAY Relay Therapeutics, Inc.2,984,125$47.7M8.36%Unchanged
ANRO Alto Neuroscience Inc1,676,558$42.2M7.39%Added +24%
DNTH Dianthus Therapeutics, Inc.354,816$30.0M5.25%Unchanged
SVRA Savara Inc.5,381,941$23.1M4.05%Added +56%
ZLAB Zai Lab Limited1,042,158$21.5M3.78%Added +273%
RLMD Relmada Therapeutics, Inc.6,912,191$19.3M3.39%Added +8%
PCVX Vaxcyte, Inc.306,047$17.3M3.03%Unchanged
ELVN Enliven Therapeutics, Inc.329,006$15.1M2.65%Unchanged
OBX Obsidian Therapeutics, Inc.1,249,943$15.0M2.63%New
SRZN Surrozen, Inc.432,040$12.7M2.22%Unchanged
SGMT Sagimet Biosciences Inc.1,400,000$12.6M2.22%New
KRSA Korsana Biosciences, Inc.338,951$12.5M2.19%New
ANTX AN2 Therapeutics, Inc.1,752,011$8.9M1.56%Added +5%
ENTA Enanta Pharmaceuticals, Inc.1,088,731$8.3M1.46%Unchanged
YARW Yarrow Bioscience, Inc.607,382$8.1M1.41%New
SABS SAB Biotherapeutics, Inc.2,198,502$6.0M1.06%Unchanged
ERAS Erasca, Inc.422,543$5.9M1.04%Unchanged
ALEC Alector, Inc.2,101,068$4.9M0.87%Unchanged
IPSC Century Therapeutics, Inc.4,059,054$4.8M0.85%Unchanged
IKT Inhibikase Therapeutics, Inc.3,581,603$4.6M0.81%Unchanged
QUIT Achieve Life Sciences, Inc.736,637$4.2M0.73%Unchanged
NERV Minerva Neurosciences, Inc.1,655,500$3.4M0.60%Unchanged
ATTO Attovia Therapeutics, Inc.228,295$3.4M0.59%New
LXEO Lexeo Therapeutics, Inc.928,593$2.9M0.51%Unchanged
CATX Perspective Therapeutics, Inc.3,693,931$2.8M0.50%Unchanged
CRVS Corvus Pharmaceuticals, Inc.231,585$2.2M0.39%Unchanged
ALMS Alumis Inc.392,574$1.6M0.28%Unchanged
LONA LeonaBio, Inc.393,701$907K0.16%Unchanged